Scripps research scientists identify blood component that turns bacteria virulent Nov 22, 2008
This study was supported by the National Institute of Allergy and Infectious Diseases, the National Institute of General Medical Sciences, the National Institutes of Health, and the Stein Beneficial Trust. About The Scripps Research Institute. (EurekAlert!)
Study of ancient and modern plagues finds common features Nov 22, 2008
The Plague of Athens is one of 10 historically notable outbreaks described in an article in The Lancet Infectious Diseases by authors from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The phenomenon of widespread, socially disruptive disease outbreaks has a long history prior to HIV/AIDS, severe acute respiratory syndrome (SARS), H5N1 avian influenza and other emerging diseases of the modern era, note the authors. (EurekAlert!)
PharmAthene signs deal with Israeli firm to market biodefense drugs Nov 20, 2008
9 million from the National Institute of Allergy and Infectious Diseases to develop and manufacture an anthrax vaccine. And in October PharmAthene said , an India-based health research management firm, would acquire a 20 percent stake in the company, pumping $13. (Baltimore Business Journal, MD)
Landmark study defines benefits of early HIV testing and treatment for infected infants Nov 20, 2008
Launched in South Africa in July 2005, CHER is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the departments of health of the Western Cape and Gauteng in South Africa. "HIV devastates the nascent immune systems of infants very quickly, yet too many HIV-infected infants do not get tested for the virus, get tested too late or get tested but lack access to lifesaving antiretroviral drugs," says Anthony S. Fauci, M.D.,... (EurekAlert!)
No Clear Answer On Why HIV Vaccine Candidates Did Not Lower Risk Of Acquiring HIV Nov 17, 2008
The study was co-sponsored by Merck & Co., Inc., which developed the vaccine, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health through the HIV Vaccine Trials Network (HVTN) ... The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases, which is a component of the U.S. National Institutes of Health. (Science Daily)
AIDS patient is reported cured Nov 14, 2008
"It's very nice, and it's not even surprising," said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "But it's just off the table of practicality.". (International Herald Tribune)
US 'super bugs' invading South America, according to UT Medical School at Houston researchers Nov 13, 2008
D. and Barbara E. Murray, M.D. The research was funded in part by the National Institute of Allergy and Infectious Diseases. . (EurekAlert!)
New Hope For HIV Treatment: Cells Exhausted From Fighting HIV Infection Can Be Revitalized Nov 12, 2008
Co-authors include Brad Jones, Mario Ostrowski, Prameet Sheth, Jessica Wong, Bahareh Vali, Feng Yun Yue, Malathy Satkunarajah, Gabor Gyenes, Martin Hyrcza, Rupert Kaul, and James Rini from the University of Toronto; Lishomwa Ndhlovu, Douglas Nixon, Aashish Jha, Brian Long, Marc Schweneker, Joan Chapman, and Joseph McCune at the Division of Experimental Medicine at UCSF; Jason Barbour, Gerald Spotts, and Frederick Hecht from the HIV/AIDS Division of the Department of Medicine at UCSF; Colin... (Science Daily)
Important Steps Towards Development Of Human Vaccine Against Malaria Nov 11, 2008
11, 2003) The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has reached a milestone in its efforts to support accelerated development of malaria. (May 24, 2007) One person dies of it every 30 seconds, it rivals HIV and tuberculosis as the world's most deadly infection and the vast majority of its victims are under five years old. (Science Daily)
Seizures Following Parasitic Infection Associated With Brain Swelling Nov 6, 2008
5, 2008) A new study by National Institute of Allergy and Infectious Diseases (NIAID) scientist Theodore E. Nash, M.D., and colleagues provides strong evidence associating seizures with areas of brain tissue swelling in people infected by a parasitic tapeworm. The swellings, called perilesional edemas, form around dead, calcified cysts that result when larvae of Taenia solium tapeworms lodge in the brain. (Science Daily)
Tiny Fungi May Have Sex While Infecting Humans Nov 4, 2008
This work was published online in the Oct. 30 edition of Current Biology, and was supported by grants from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, and by the Canadian Institutes for Health Research. Other authors on this study include Nicolas Corradi and Patrick J. Keeling of the Canadian Institute for Advanced Research, Department of Botany, University of British Columbia Vancouver; Edmond J. Byrnes III of the Duke Department of Molecular... (Science Daily)
Nature study demonstrates that bacterial clotting depends on clustering Nov 3, 2008
Bacteria can directly cause human blood and plasma to clota process that was previously thought to have been lost during the course of vertebrate evolution, according to new research at the University of Chicago, National Institute of Allergy and Infectious Diseases, and Institut Pasteur in Paris ... Researchers at the National Institute of Allergy and Infectious Diseases, Institut Pasteur in Paris, and Ben-May Department for Cancer Research at the University of Chicago co-authored the paper. (EurekAlert!)
Persistent bacterial infection exploits killing machinery of immune cells Nov 3, 2008
The research, supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is the work of the laboratories headed by Peter Murray, Ph. D., at St. Jude Children's Research Hospital in Memphis, Tenn. (EurekAlert!)
HIV-infected Patients Should Start HAART Sooner, Study Suggests Oct 31, 2008
IeDEA, a global network of clinics that serve HIV patients and collect data important to key HIV/AIDS research questions, was initiated by and is funded in part by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). IeDEA is co-funded by the National Cancer Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. (Science Daily)
Study: HIV patients should start drugs early Oct 28, 2008
"The data are rather compelling that the risk of death appears to be higher if you wait than if you treat," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, which helped pay for the study. If the results prompt doctors to change practice - as Fauci and other AIDS specialists predict - several hundred thousand Americans who are not taking AIDS drugs now would be advised to start. (San Francisco Chronicle)
Anthrax vaccine to be studied in Seattle Oct 27, 2008
The private, non-profit Benaroya Research Institute was awarded one of 14 grants in a $74 million program launched yesterday by the National Institute of Allergy and Infectious Diseases. The project aims to find better vaccines or drugs to protect against infectious diseases such as influenza, West Nile virus or bioterrorism agents such as anthrax. (Yahoo News -- Anthrax)
Tick-borne Encephalitis Virus Reveals Its Access Code Oct 23, 2008
10, 2005) Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have made the surprising discovery that flaviviruses, which cause such. (Mar. (Science Daily)
SanDisk sinks as Samsung drops buyout bid Oct 23, 2008
Trius Therapeutics has received a $28 million contract from the National Institute of Allergy and Infectious Diseases for the development of novel antibiotics directed against multiple bacterial pathogens. Under the five-year contract, Trius will develop new drugs that could be used in biodefense for pathogens most likely to be used in a terrorist attack. (San Diego Union-Tribune -- Business)
Non-AIDS Deaths In People With HIV Linked To Inflammation And Coagulation, Study Suggests Oct 22, 2008
(May 15, 2008) On the 25th anniversary of the first scientific article linking a retrovirus to AIDS, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases reflects in an. (July 10, 2007) HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to a recent article. (Science Daily)
Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment Oct 22, 2008
The new report, published in the open access journal PLoS Medicine, is a further analysis of the "Strategies for Management of Antiretroviral Therapy" (SMART) study supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (). SMART, which ended in 2006, compared the standard practice of continuous ART to suppress HIV in infected individuals with episodic ART based on CD4+ T-cell counts. (EurekAlert!)
Integrated BioTherapeutics to develop vaccine Oct 16, 2008
After those studies, the National Institute of Allergy and Infectious Diseases may exercise options to the contract that go as far as a Phase 2 clinical trial. This summer, IBT moved its headquarters from the Frederick Innovative Technology Center. (Washington Business Journal, DC)
World's Poor Will Be Biggest Victims Oct 15, 2008
Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said "the increases in the budget we had hoped for will not be forthcoming.". Alan Bernstein, head of Global Vaccine Enterprise, said the financial meltdown is "not good news for research in general and vaccine research in particular.". (Time.com)
3 Europeans share Nobel Prize in medicine Oct 7, 2008
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland, agreed there's no doubt the French scientists first identified the virus. He said they, and zur Hausen, deserved the Nobel. (Atlanta Journal-Constitution)
German, 2 French researchers share Nobel Prize in medicine Oct 7, 2008
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said, "Clearly the awardees are totally deserving." But he noted that Gallo suffered from the Nobel judges' decision to honor two discoveries. That's because the award goes to three researchers at most. (USA Today -- Tech)
Nobels Awarded for AIDS, Cancer Virus Research Oct 7, 2008
Dr. Anthony Fauci, a prominent AIDS researcher and director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. said the French scientists clearly identified HIV first and deserved Monday's honor. (Newsmax)
COLD VS. FLU: How to tell the difference Oct 4, 2008
The National Institute of Allergy and Infectious Diseases says differences include these. Fever. (USA Today -- News)
Study adds 50 years to HIV history Oct 4, 2008
Understanding the genetic history of HIV and how it has evolved gives scientists a level of insight into how the virus may mutate in the future, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in the US.. This understanding can help researchers develop new treatment or prevention approaches that might be effective in the long term, Fauci said. (Calcutta Telegraph)
HIV/AIDS Pandemic Began Around 1900, Earlier Than Previously Thought; Urbanization In Africa Marked Outbreak Oct 3, 2008
The research, led by Michael Worobey, an assistant professor of ecology and evolutionary biology at The University of Arizona in Tucson, was co-sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the David and Lucile Packard Foundation. The findings are published in the current issue of the journal Nature. (Science Daily)
Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center Oct 3, 2008
Current members of the Consortium include IAVI, The Scripps Research Institute, Academia Sinica, Cornell University, the Dana-Farber Cancer Institute, the Children's Hospital of Philadelphia, the Karolinska Institute, Harvard Medical School, the Indian Institute of Science, Oxford University, the Institute for Research in Biomedicine, the International Centre for Genetic Engineering and Biotechnology, the University of Pennsylvania, the University of Washington, the University of Wisconsin and... (EurekAlert! -- Business News)
HIV jumped to humans earlier than once thought Oct 3, 2008
The new work is "clearly an improvement" over the previous estimate of around 1930, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. His institute helped pay for the work. (Globe and Mail -- International)
DNA of good bacteria drives intestinal response to infection Oct 3, 2008
D., and her colleagues in the Laboratory of Parasitic Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. A person normally has 300 to 500 species of beneficial bacteria, known as commensals, in their intestines. (EurekAlert!)
Plant Antioxidant May Protect Against Radiation Exposure Sep 25, 2008
The study was funded by a 10 million grant from the National Institute of Allergy and Infectious Diseases to establish the Center for Medical Countermeasures Against Radiation at the University of Pittsburgh. Adapted from materials provided by , via , a service of AAAS.. (Science Daily)
Cost-effectiveness Of Genetic Screening To Guide Initial HIV Treatment Evaluated Sep 24, 2008
The study was supported in part by the National Institute of Allergy and Infectious Diseases and the National Institute on Drug Abuse. Adapted from materials provided by. (Science Daily)
Here’s a list of local issues that have been covered recently in the Gazette-Times and the status of those stories: (51) Sep 21, 2008
7 million research award from the National Institute of Allergy and Infectious Diseases follows earlier grants totaling nearly 2. 1 million for the project to develop the drug, labeled ST-193. (Corvallis Gazette Times, OR)
Type 1 diabetes may result from good genes behaving badly Sep 20, 2008
In a study supported by the National Institute of Allergy and Infectious Diseases, (NIAID) part of the National Institutes of Health, the Stanford team, led by C. Garrison Fathman, M.D., studied differences in gene expression between two groups of mice. The first group, non-obese diabetic mice, spontaneously develop type 1 diabetes. (EurekAlert!)
Monitoring exhaled nitric oxide does not help manage asthma Sep 20, 2008
The study was conducted by the Inner City Asthma Consortium (ICAC), which is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The Sept. 20 issue of The Lancet reports the ICAC findings. (EurekAlert!)
Capturing Replication Strategies Used By SARS Viruses In Their Bid To Spread Sep 19, 2008
21, 2004) An experimental vaccine based on a critical piece of the SARS virus protects mice from SARS infection, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the. . (Science Daily)
Genetic Mutation That May Predict Organ Rejection Identified Sep 17, 2008
Sindhi's research is supported by the National Institute of Allergy and Infectious Diseases, the Children's Hospital of Pittsburgh Foundation, and the Hillman Foundation. Study collaborators include Daniel E. Weeks, PhD, and associates from the Department of Human Genetics at the University of Pittsburgh, and Hakon Hakonarson, MD, from the Center for Applied Genomics at The Children's Hospital of Philadelphia. (Science Daily)
NIH Funds SIGA Lassa Antiviral Program Sep 15, 2008
This award provides an additional $3,655,000 from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), on top of the $2,089,000 in funding that SIGA has already received from this grant. Lassa fever is found in West Africa and is endemic in certain areas of this region, where it can be a significant cause of morbidity and mortality. (Primezone Releases)
Killing Bacteria Isn't Enough To Restore Immune Function After Infection Sep 13, 2008
The work was supported by the National Institute of Allergy and Infectious Diseases. Adapted from materials provided by. (Science Daily)
St. Louis University to use volunteers in avian-flu vaccine tests Sep 10, 2008
The vaccine study is funded by the National Institute of Allergy and Infectious Diseases. The 500 participants will be recruited by research centers in St. Louis, Atlanta and Seattle. (Atlanta Journal-Constitution -- Health)
Doubts Grow Over Flu Vaccine in Elderly Sep 2, 2008
In 2005, Dr. Simonsen, who was then at the National Institute of Allergy and Infectious Diseases in Bethesda, Md. published a paper in The Archives of Internal Medicine that found something odd: even though the percentage of older people who got an annual flu shot more than tripled from 1980 to 2001, there was no corresponding drop in the death rate. (Atlanta Journal-Constitution -- Health)
IDRI gets $6.3M grant to study new tuberculosis vaccine Aug 28, 2008
The four-year grant is from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Tuberculosis vaccines haven t changed much in many years, according to researchers at the Seattle nonprofit. (Puget Sound Business Journal, WA)
Moffitt wins federal financing for HPV study Aug 26, 2008
The National Institute of Allergy and Infectious Diseases of the National Institutes of Health has awarded a $2. 08 million grant to Moffitt. (Tampa Bay Business Journal, FL)
Sars patients can provide therapy Aug 25, 2008
A team from the US National Institute of Allergy and Infectious Diseases then tested the most effective of these antibodies in mice and found they prevented the virus from multiplying in the respiratory system. Dr Lanzavecchia said: "At present there is no immunological treatment for Sars, and a vaccine may take several years to produce. "Our approach produces protective antibodies that would provide immediate protection against the Sars virus. (Yahoo News -- SARS)
Molecule That Keeps Pathogens Like Salmonella In Check Uncovered Aug 23, 2008
5 million grant from the National Institute of Allergy and Infectious Diseases to develop a new antimicrobial compound to target bacterial pathogens such as Salmonella, E coli and F tularensis. Dr. Sperandio is the principal investigator. (Science Daily)
Bacterial Pneumonia Caused Most Deaths In 1918 Influenza Pandemic Aug 21, 2008
20, 2008) The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Instead, most victims succumbed to bacterial pneumonia following influenza virus infection. (Science Daily)
Leishmaniasis Parasites Evade Death By Exploiting Immune Response To Sand Fly Bites Aug 19, 2008
In a new study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, scientists have discovered L. major does its damage by not only evading but also by exploiting the body's wound-healing response to sand fly bites, as reported in the August 15 issue of Science. See also. (Science Daily)
Why Some Infected With HIV Remain Symptom Free Without Antiretroviral Drugs Aug 14, 2008
Funding for this latest study was provided by the National Institute of Allergy and Infectious Diseases, a member of the National Institutes of Health (NIH). In addition to Blankson, other Hopkins researchers involved in these studies were Justin Bailey, M.D., Ph. (Science Daily)
Hope: An Overlooked Tool In The Battle Against HIV/AIDS Aug 11, 2008
(May 15, 2008) On the 25th anniversary of the first scientific article linking a retrovirus to AIDS, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases reflects in an. (Aug. (Science Daily)
War on AIDS: Money nightmare seems set to return Aug 9, 2008
"It is extremely improbable that we will have the structure and financial ability to take on all the people who require ART [antiretroviral therapy] and then treat them for life," Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), warned on Wednesday ... US National Institute of Allergy and Infectious Diseases. (Yahoo News -- Top Stories)
New AIDS vaccine blueprint calls for more focus Aug 6, 2008
The approach mirrors one being taken by the National Institute of Allergy and Infectious Diseases, part of the U.S. government's National Institutes of Health, to funnel spending more to lab work and animal tests rather than expensive large-scale vaccine trials on humans. The nonprofit IAVI is helping to test five vaccines along with the National Institutes of Health, academic research institutions and companies such as Targeted Genetics , Therion Biologics, Crucell NV and... (AlertNet)
Is there still hope for an HIV vaccine? Aug 6, 2008
Last month, the US National Institute of Allergy and Infectious Diseases (NIAID) announced it would not move ahead with a vaccine trial involving 8,500 participants, which was intended to test a candidate with similarities to the one that failed last year. These developments have left the vaccine field reeling, with people in some quarters calling for public funding of AIDS vaccine research to be ended or diverted toward existing HIV treatment and prevention interventions. (AlertNet)
Commentary: AIDS chief still hopeful for cure Aug 6, 2008
Anthony S. Fauci, M.D., is director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. All About. (CNN -- Health)
Students with food allergies often not prepared Aug 6, 2008
7 percent of adults, according to the National Institute of Allergy and Infectious Diseases. Among college students, researchers found that only 50 percent of the students who identified themselves as having an allergy to a food said they always avoided the food. (EurekAlert!)
Novel method to create personalized immunotherapy treatments Aug 6, 2008
This work was funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. N01-AI-60019. About the Arcelis Technology. (EurekAlert!)
Long-term HIV treatment may reduce risk for atherosclerosis Aug 5, 2008
The study was funded by the National Institute of Allergy and Infectious Diseases, National Cancer Institute and National Heart, Lung, and Blood Institute. . (EurekAlert!)
• Anthrax blend led FBI to Ivins Aug 4, 2008
Based on analyses performed at the Institute for Genomic Research, Venter said the culprit "almost had to be a government scientist." The institute's analysis was completed under contract to the FBI and the National Institute of Allergy and Infectious Diseases. Venter said federal investigators within the last two years retrieved the anthrax evidence from the institute. (Q13.com, WA)
Anthrax vaccine to be studied in Seattle Aug 4, 2008
The private, non-profit Benaroya Research Institute was awarded one of 14 grants in a $74 million program launched yesterday by the National Institute of Allergy and Infectious Diseases. The project aims to find better vaccines or drugs to protect against infectious diseases such as influenza, West Nile virus or bioterrorism agents such as anthrax. (Yahoo News -- Anthrax)
A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control Aug 3, 2008
The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases, which is a component of the U.S. National Institutes of Health. The Network and NIAID have a close, cooperative working relationship, with shared attention to the intellectual and scientific issues. (PR Newswire)
Circumcision Clinic Has African Men Lining Up to Prevent AIDS Infection Aug 2, 2008
The foreskin has also been shown in studies to be rich cells that carry HIV into the body, said Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases. Since Bailey's 2006 study, more African health leaders are trying to raise circumcision rates, said , executive secretary of Rwanda's National Commission to Fight AIDS, in an interview last month at the UN in New York. (Bloomberg)
Emergent BioSolutions applies for anthrax vaccine award Aug 2, 2008
Emergent recently received a federal grant from the National Institute of Allergy and Infectious Diseases for a five-year allotment for its next-generation anthrax treatment vaccine. Reader Comments. (Washington Business Journal, DC)
Black U.S. AIDS rates rival African nations' Jul 31, 2008
"Five percent of the entire population (in DC) is infected... that's comparable to countries like Uganda or South Africa," , director of the National Institute of Allergy and Infectious Diseases, told CNN for the recent "Black in America" documentary. According to this report, if black Americans made up their own country, it would rank above Ethiopia (420,000 to 1,300,000) and below Ivory Coast (750,000) in HIV population. (CNN -- Health)
Zapping microbes with lasers and enzymes Jul 29, 2008
I think its a great idea, said Frank DeLeo, acting chief of the Laboratory of Human Bacterial Pathogenesis at the National Institute of Allergy and Infectious Diseases Rocky Mountain Laboratories in Hamilton, Mont. DeLeo noted that other researchers have taken a similar approach with the photo-activated and FDA-approved dye methylene blue, which targets bacterial DNA. An increasing body of literature, he said, suggests that this general strategy could work well not only for MRSA but... (MSNBC -- Terrorism)
AIDS vaccine search in US makes major U-turn after letdowns Jul 28, 2008
Anthony S Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), and his colleagues announced the turnabout in an article in the Science magazine, which released the item a day before its formal publication Friday. In an interview with DPA ahead of the embargoed publication, Fauci said that his federally fund 00004000 ed institute - which distributes about 80 percent of the money spent worldwide on vaccine research - would "rev up the burners" to tackle the... (Economic Times)
AIDS-Prevention Drug Trial for Breastfed Babies Splits Researchers on Use Jul 25, 2008
The U.S. National Institute of Allergy and Infectious Diseases and the Fogarty International Center also funded the study. To contact the reporter on this story: at. (Bloomberg -- Asia)
New Vaccine May Protect Against All Four Strains Of Dengue Virus Jul 24, 2008
19, 2003) Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have created a promising vaccine against West Nile virus by replacing parts of a distantly related virus with proteins. (Mar. (Science Daily)
Government to release revised US HIV estimates Jul 23, 2008
In June, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he believed the numbers had risen from 40,000 to 50,000 a year, although the CDC denied he had seen the new estimates. Late on Tuesday, the CDC said it would release the new estimates on August 3 in the Journal of the American Medical Association. (Scientific American)
US Cancels Major AIDS Vaccine Trial Jul 22, 2008
So, basically a vector is the vehicle that we (use to) try to deliver the elements of HIV (AIDS virus) to teach the immune system," he says. Warren says that this vaccine candidate also could not infect a person with HIV. "So, all of this caused a lot of extra analysis about the PAVE 100 trial," he says. Last Thursday, Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, decided to cancel it. Warren considers this "a very big point" in AIDS vaccine history but is... (Voice of America)
What's Next for the HIV Vaccine? Jul 20, 2008
On July 17, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, scrapped plans for a large clinical trial of the government's most advanced HIV vaccine candidate to date. The vaccine, a two-shot injection, was designed to fight HIV infection a new way by activating the body's cell-based immune responses rather than by relying on antibodies to HIV.. (TIME)
Booster Vaccination May Help With Possible Future Avian Influenza Pandemic Jul 19, 2008
(June 1, 2004) The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two contracts to support the production and clinical testing of an. (Dec. (Science Daily)
1998: Syphilis Genome Sequenced; 2008: Syphilis on the Rise Jul 18, 2008
At the time, Penelope Hitchcock, the chief of the sexually transmitted disease branch of the National Institute of Allergy and Infectious Diseases (NIAID), hailed the work as critical to developing better drugs. NIAID director Anthony Fauci added the genome would boost efforts to develop a preventative vaccine. (Scientific American)
US scientists scrap major AIDS vaccine test Jul 18, 2008
The National Institute of Allergy and Infectious Diseases (NIAID), part of the government's National Institutes of Health, said after consulting scientists and advocacy groups it "has determined that it will not conduct the HIV vaccine study known as PAVE 100.". "However, NIAID believes the vaccine developed by its Vaccine Research Center (VRC) is scientifically intriguing and sufficiently different from previously tested HIV vaccines to consider testing it in a smaller, more focused clinical... (Sydney Morning Herald -- World)
Trial for Vaccine Against H.I.V. Is Canceled Jul 18, 2008
The official who canceled the government trial, Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said it was becoming clearer that more fundamental research and animal testing would be needed before an H.I.V. vaccine was ever marketed. Scientists say that developing a vaccine against H.I.V. is one of the most difficult scientific endeavors in history because of the uncanny nature of the virus. (Atlanta Journal-Constitution -- Health)
Gene Signatures For Scleroderma Discovered Jul 17, 2008
20, 1998) A National Institute of Allergy and Infectious Diseases (NIAID) grantee in Seattle has found experimental data to support a new hypothesis about the genesis of scleroderma, an autoimmune disorder. (Nov. (Science Daily)
Exhausted B Cells Hamper Immune Response To HIV Jul 15, 2008
Now, researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have shown that a similar type of exhaustion strikes another important brigade of immune system soldiers: the B cells that make virus-fighting proteins called antibodies. In most HIV-infected individuals not receiving antiretroviral therapy, the virus replicates continuously, causing systemic disturbances that include changes in certain subsets of B cells that... (Science Daily)
BAY AREA BIZ Jul 13, 2008
National Institute of Allergy and Infectious Diseases, United States and Japan Immunosenescence Workshop, Friday through July 21, Hyatt at Fisherman's Wharf. Chemical Producers ibutors Association, annual meeting, next Sunday through July 25, Argonaut Hotel. (San Francisco Chronicle -- Business)
New Hope against the Cold Sore Virus Jul 4, 2008
"This provides a new strategy to use for seeking a cure," said Christopher Beisel, a virologist and program officer at the U.S. National Institute of Allergy and Infectious Diseases, which funded the Duke research. "However, I always caution people that when something like this comes out, and people start talking about cures, that there's a long way to go, starting with animal experiments.". (MEDLINEplus)
Penn animal study identifies new DNA weapon against avian flu Jul 2, 2008
VGX Pharmaceuticals and the National Institute of Allergy and Infectious Diseases provided partial funding for this research. Dr. Weiner sits on the scientific advisory board of VGX, and collaborates with Wyeth, Merck, BMS, Althea, and Virxsys, as well as other companies on DNA vaccine technologies. (EurekAlert!)
The Buzz on Mosquito Protection Jul 1, 2008
Recent reports from the National Institute of Allergy and Infectious Diseases (NIAID) state that widespread appearance of Dengue Fever in the continental United States is a real possibility. The American Mosquito Control Association (AMCA) is an international organization of nearly 2,000 public health professionals dedicated to preserving health through safe, environmentally-sound mosquito control programs since 1935. (Sebastopol Sonoma West Publishing, CA)
Lyme Disease Bacterium Came From Europe Before Ice Age Jun 30, 2008
(June 21, 2001) A new test developed with funding from the National Institute of Allergy and Infectious Diseases (NIAID) has been shown to be highly accurate and sensitive for detecting antibodies to Lyme disease. (June 6, 2000) New research from scientists at the University of Georgia, just published in the journal Science, demonstrates that Borrelia burgdorferi, the bacterium that causes Lyme disease in humans, is the. (Science Daily)
Nintendo Numbing Jun 26, 2008
Besides Bubba, among the 250 headliners: Homeland Security Secretary Michael Chertoff; former Supreme Court Associate Justice Sandra Day O'Connor; Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases; National Endowment for the Arts Chairman Dana Gioia; Austan Goolsbee, economic adviser to soon-to-be-crowned Democratic presidential nominee Sen. Barack Obama; and Douglas Holtz-Eakin, policy adviser to the presumptive Republican presidential pick Sen. (Townhall.com)
Potential Role Of Fish-based Fatty Acids In Resolving, Preventing Asthma Jun 26, 2008
The research, supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, was led by a research team at Brigham and Women's Hospital and Harvard Medical School. Resolvin E1 (RvE1) is a metabolic product of an omega-3 fatty acid found in cold-water fish such as salmon, mackerel and anchovies. (Science Daily)
Exotic illnesses afflict American poor Jun 25, 2008
Dr. Lee Hall, chief of parasitology and international programs at the National Institute of Allergy and Infectious Diseases, said his agency funded research into the diseases, but primarily as global, not national, problems. "Do we need better data? We probably do, but that's probably true . . . for infectious diseases of the poor in general.". (Los Angeles Times)
SeraCare beats odds to rejoin Nasdaq Jun 21, 2008
7 million federal contract with the National Institute of Allergy and Infectious Diseases and sold its genomics unit in Cambridge for $2 million in cash, plus royalties. SeraCare emerged from bankruptcy in May 2007 with the same group of shareholders and a plan to repay its creditors in full. (Boston Globe)
Archives: National Institute of Allergy and Infectious Diseases
